Amylyx Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.87
0.06
(1.57%)
Volume:
711,856
52 week range:
1.58 - 7.27
Market Cap:
342.892M
Company Description:
Amylyx Pharmaceuticals, Inc. develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product candidature includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid.